Endogenous thrombopoietin serum levels during multicycle chemotherapy.
about
The molecular mechanisms that control thrombopoiesisHuman plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.Serum levels of endogenous thrombopoietin and granulocyte-colony stimulating factor in patients with acute or lymphoma type adult T-cell leukemia during multicycle chemotherapy.Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma.Investigation of the pharmacokinetics of romiplostim in rodents with a focus on the clearance mechanism.Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy.Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.Novel mechanisms of platelet clearance and thrombopoietin regulation.Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance.The (patho)physiology of megakaryocytopoiesis: from thrombopoietin in diagnostics and therapy to ex vivo generated cellular products.Regulating billions of blood platelets: glycans and beyond.High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.
P2860
Q24536138-395D5A5E-B186-49B6-B90E-76B21D0F1AB4Q33342032-C4C61552-1171-4E90-BF77-C5A5439473E7Q33342331-16B4D430-9602-4D62-9574-74A333ADD8D6Q33365351-9FF0C1C4-7C97-4020-8D1D-E4E443B85F20Q33367821-F8991529-1950-40A6-A061-7136DBA1D49FQ33394842-26D92634-CD5E-488F-B4F2-297ED02C8D9AQ33397918-FE635A4F-2A90-44EE-978F-15C85F777D0AQ33414742-8910AD7B-319D-447C-AF8E-C4CDBD922724Q33419210-55404CD8-51E9-4BFF-90AE-2DDDD9A74F15Q33424241-AD031E30-884E-402D-BCA0-1CFEFB0980DAQ33587921-D1A7FEF6-3173-41AC-8576-D1FEFB369253Q35812934-1C360E7B-DB1A-47FB-AC1C-F73A428F3BF5Q36169258-CC405DCD-9FD3-4A79-A5DB-DDA09BF05F5DQ43662943-1B3ABE30-5F77-44A0-960F-4DCFE10DD941
P2860
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@ast
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@en
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@nl
type
label
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@ast
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@en
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@nl
prefLabel
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@ast
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@en
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@nl
P2093
P2860
P1476
Endogenous thrombopoietin serum levels during multicycle chemotherapy.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.1999.01459.X
P407
P577
1999-06-01T00:00:00Z